Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)

Johnson & Johnson has disclosed Share-based Compensation across 18 years of filings, most recently posting -$950.0 million for Q2 2026.

• In Q2 2026, Share-based Compensation fell 119.48% year-over-year to -$950.0 million; the TTM figure through Jun 2026 stood at -$1.3 billion (down 116.15% YoY), while the FY2025 annual figure was $6.2 billion, up 459.17% from the prior year.
• Share-based Compensation came in at -$950.0 million for Q2 2026 at Johnson & Johnson, down from -$349.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.9 billion in Q2 2025 to a low of -$3.2 billion in Q1 2024.
• Average Share-based Compensation over 5 years is $553.5 million, with a median of $225.5 million recorded in 2023.
• The largest YoY upside for Share-based Compensation was 1153.15% in 2024 against a maximum downside of 449.62% in 2024.
• Over 5 years, Share-based Compensation stood at -$995.0 million in 2022, then soared by 312.46% to $2.1 billion in 2023, then slumped by 136.33% to -$768.0 million in 2024, then sank by 93.49% to -$1.5 billion in 2025, then soared by 36.07% to -$950.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were -$950.0 million in Q2 2026, -$349.0 million in Q1 2026, and -$1.5 billion in Q4 2025.